1. Market Research
  2. > Pathology Industry

lymphoma Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Instrument, Flow Cytometry, Pap Smear, Nuclear Imaging, Oncology, Therapeutics, Antibody, Clinical Trial, Nuclear Medicine, Pharmaceutical, Biomarker, Cancer Diagnostic, Radiopharmaceutical, Rituximab, Therapy.


 
1-10 of about 200 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Global Lymphoma Partnering 2010 to 2016

Global Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

 Lymphoblastic Lymphoma-Pipeline Insights, 2016

Lymphoblastic Lymphoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Lymphoblastic Lymphoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. ...

 Indolent Lymphoma-Pipeline Insights, 2016

Indolent Lymphoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Indolent Lymphoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The ...

 T-Cell Lymphomas-Pipeline Insights, 2016

T-Cell Lymphomas-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ T-Cell Lymphomas-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Lymphomas. The De ...

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

 Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Peripheral ...

About 2 300 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • January 2016
    178 pages
  • Cancer  

    Rituximab  

    Oncology  

  • United Kingdom  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.